From One-Size-Fits-All to Personalized Treatment: An article by Marleen Kok et al.

Maryam Lustberg shared on LinkedIn:

“From One-Size-Fits-All to Personalized Treatment: Challenges and Potential Solutions.

Opportunities for biomarker driven precision therapy and supportive care.”

Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer

Authors: Marleen Kok, Robbert-Jan Gielen, Sylvia Adams, Jochen K. Lennerz, Priyanka Sharma, Sibylle Loibl, Erin Reardon, Gabe Sonke, Sabine Linn, Suzette Delaloge, Denis Lacombe, Tim Robinson,  Sunil Badve, Miguel Martin, Justin M. Balko, Michail Ignatiadis, Giuseppe Curigliano, Antonio C. Wolff, Elizabeth A. Mittendorf, Sherene Loi, Lajos Pusztai, Sara M. Tolaney, Roberto Salgado,

More posts featuring Maryam Lustberg on oncodaily.com

Maryam Lustberg MD MPH is a breast medical oncologist and currently serves as Chief of Breast Oncology and Director of the Breast Center at Yale Cancer Center in New Haven Connecticut. She is the co-chair of Symptom Intervention for Alliance Clinical Trials and is immediate Past President of MASCC, an international organization devoted to improving cancer supportive care throughout the globe.

Clinically she treats men and women with all stages of breast cancer with a focus on personalizing all aspects of cancer care incorporating latest advances in therapeutics as well as optimization of symptom management strategies and delivery of holistic person centered care. Her research is centered on biomarkers of therapeutic response and cancer treatment related toxicities.